Raine Study

To access the Raine Study Website please click here

The Western Australian Pregnancy Cohort (Raine) Study is one of the largest successful prospective cohorts of pregnancy, childhood, adolescence and now early adulthood to be carried out anywhere in the world. The cohort was established between 1989 and 1991 to determine how events during pregnancy and childhood influence health in later life. 2900 pregnant women entered the study and 2868 live births were recruited into the Raine Study cohort.

These families have provided environmental, developmental and health information over the past 25 years providing a unique and valuable resource covering a wide range of health areas.

Follow up assessment of the cohort has been conducted at birth, 1, 2, 3, 5, 8, 10, 13, 16, 18, and 20 years of age. The cohort completed the 22 year review in June 2014, concentrating on sleep and asthma. 

The Raine Study is a valuable resource for Western Australian researchers. There are currently more than 150 researchers utilising the Raine Study. The investigators bring expertise from 25 broad areas of research including; asthma and atopy, cardiovascular and metabolic heath, childhood developmental growth, dental health, diabetes,  genetic epidemiology, gastro-enterology, infection and immunity, mental health, musculoskeletal development, nutrition, physical activity, ophthalmology, pregnancy and birth, reproductive health, sleep and risk taking behavior.

Collaboration between the Raine Study and national and international researchers are extensive and continuing to develop which value adds to the cohort and expands research and funding opportunities. The Raine Study is a member of 14 consortia established to amalgamate genome wide association data.

Subscribe to our e-news

Mailing list terms and Conditions

By subscribing to this service you are giving Telethon Kids Institute permission to contact you direct via email. You may unsubscribe at anytime via the emails sent to you.

Your email address will not be disclosed to any third party.

Please agree with the Terms & Conditions.